Use Of SLURP1 As An Imunomodulatory Molecule In The Ocular Surface
Therapeutically Effective Amount Of A SLURP1 Polypeptide
Inventors: Shivalingappa Kottur Swamynathan: Sudha Swamynathan: Kristine Ann Gallegos Buela: Robert Lee Hendricks
Patent Number: 14/821,567
Abstract
Methods for treating inflammation are disclosed, such as for treating ocular inflammation. In some embodiments, the ocular inflammation is inflammation of an ocular surface, such as keratitis. The methods include administering to a subject with inflammation a therapeutically effective amount of SLURP1, or a nucleic acid encoding SLURP1, thereby treating the inflammation.